Otsuka America Pharmaceutical, Inc.
NDC labeler code: 59148
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- AripiprazoleAbilify, Opipza, Abilify Asimtufii · 8 products
- BrexpiprazoleRexulti · 6 products
- TolvaptanSamsca, Jynarque · 4 products
- Centanafadine hydrochlorideSimtriyo · 3 products
- Dextromethorphan hydrobromide and quinidine sulfateNuedexta · 1 product
- SibeprenlimabVoyxact · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| July 24, 2026 | NDA218145 | Centanafadine hydrochloride SIMTRIYO | Otsuka Pharmaceutical Co Ltd |
| November 25, 2025 | BLA761434 | Sibeprenlimab VOYXACT | Otsuka Pharm Co Ltd |
| April 27, 2023 | NDA217006 | Aripiprazole ABILIFY ASIMTUFII | Otsuka |
| April 23, 2018 | NDA204441 | Tolvaptan JYNARQUE | Otsuka |
| July 10, 2015 | NDA205422 | Brexpiprazole REXULTI | Otsuka |
| October 29, 2010 | NDA021879 | Dextromethorphan hydrobromide and quinidine sulfate NUEDEXTA | Otsuka America Pharm |
| May 19, 2009 | NDA022275 | Tolvaptan SAMSCA | Otsuka |
| November 15, 2002 | NDA021436 | Aripiprazole ABILIFY | Otsuka |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2024
-
April 9, 2024 · Class III · Ongoing · D-0466-2024 · Aripiprazole
Cross Contamination with Other Products
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
-
April 9, 2024 · Class III · Ongoing · D-0468-2024 · Aripiprazole
Cross Contamination with Other Products
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
-
April 9, 2024 · Class III · Ongoing · D-0467-2024 · Aripiprazole
Cross Contamination with Other Products
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
-
April 9, 2024 · Class III · Ongoing · D-0469-2024 · Aripiprazole
Cross Contamination with Other Products
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
2012
-
November 2, 2012 · Class II · Terminated · D-181-2013 · Aripiprazole
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026